Anchiano Therapeutics

Form S-8

Anchiano Therapeutics Ltd. filed this Form S-8 on 07/22/2019

Document Outline:

PDF Form S-8 (LINK)

PDF Exhibit 5.1 (LINK)

PDF Exhibit 23.1 (LINK)

PDF Exhibit 99.2 (LINK)

PDF Graphic (LINK)

PDF Graphic (LINK)

PDF Complete Text Submission File  (LINK) 

 

 

Link to PR

NASDAQ: CMMB

 

Website Terms and Conditions of Use

View/Download 

Contact

Investor Relations:

Irina Koffler LifeSci Advisors, LLC

Email: ir@chemomab.com

Phone: +1-917-734-7387

 

Chemomab Therapeutics:

Sharon Elkobi VP, Business Development

Email: bd@chemomab.com

Phone: +972773310156

 

Anchiano Therapeutics © 2021